Resources Contact Us Home
Clostridium perfringens alpha toxin proteins

Image Number 6 for United States Patent #7982006.

This invention pertains in part to the development of a vaccine for poultry against necrotic enteritis (NE). The vaccine utilizes a protective antigen that is a mutated, full-length, non-toxic Clostridium perfringens (Cp) .alpha.-toxin protein (Mcpa). Utility of this vaccine was demonstrated by reduction of lesion severity in NE challenge trails, for example. Also disclosed herein are novel approaches for producing this vaccine in significant quantities. One exemplified approach involves producing NE vaccine (mutated alpha toxin) in bacterial expression systems, preferably utilizing the Pseudomonas fluorescens system, for commercial use in controlling NE in the poultry industry. The subject vaccines can be administered preferably to chickens in several different ways. A novel, Type VI alpha toxin from chicken isolates of Cp is also disclosed.

  Recently Added Patents
Economic filtering system for delivery of permission based, targeted, incentivized advertising
Flame-protected impact-modified polycarbonate compositions
Methods for enhancing tantalum filament life in hot wire chemical vapor deposition processes
Vehicle fender
Secure Flash-based memory system with fast wipe feature
Systems and methods for tracking power modulation
System and method for wireless messaging in a wireless communication system
  Randomly Featured Patents
Agents for controlling harmful fungi
Multistage aqueous dispersion of polymer particles having a soft core and hard shell
Selective applications of weed control chemicals
Air gap with deodorizer apparatus and method of use
Iron type golf club head
Multi-gate molding heater assembly
Storing and accessing TCP connection information
Adaptive equalizer
Communication system for a rail vehicle consist and method for communicating with a rail vehicle consist
Color separation into plural ink components including primary color ink and spot color ink